The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus
Abstract
Alzheimer's disease (AD) is the leading type of dementia worldwide. With an increasing burden of an aging population coupled with the lack of any foreseeable cure, AD warrants the current intense research effort on the toxic effects of an increased concentration of beta‐amyloid (Aβ) in the brain. Glutamate is the main excitatory brain neurotransmitter and it plays an essential role in the function and health of neurons and neuronal excitability. While previous studies have shown alterations in expression of glutamatergic signaling components in AD, the underlying mechanisms of these changes are not well understood. This is the first comprehensive anatomical study to characterize the subregion‐ and cell layer‐specific long‐term effect of Aβ 1–42 on the expression of specific glutamate receptors and transporters in the mouse hippocampus, using immunohistochemistry with confocal microscopy. Outcomes are examined 30 days after Aβ 1–42 stereotactic injection in aged male C57BL/6 mice. We report significant decreases in density of the glutamate receptor subunit GluA1 and the vesicular glutamate transporter (VGluT) 1 in the conus ammonis 1 region of the hippocampus in the Aβ 1–42 injected mice compared with artificial cerebrospinal fluid injected and naïve controls, notably in the stratum oriens and stratum radiatum. GluA1 subunit density also decreased within the dentate gyrus dorsal stratum moleculare in Aβ 1–42 injected mice compared with artificial cerebrospinal fluid injected controls. These changes are consistent with findings previously reported in the human AD hippocampus. By contrast, glutamate receptor subunits GluA2, GluN1, GluN2A, and VGluT2 showed no changes in expression. These findings indicate that Aβ 1–42 induces brain region and layer specific expression changes of the glutamatergic receptors and transporters, suggesting complex and spatial vulnerability of this pathway during development of AD neuropathology. image Read the Editorial Highlight for this article on page 7. Cover Image for this issue: https://doi.org/10.1111/jnc.14763.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous study revealed decreased Vglut in AD model mice (Yeung et al., 2020).”
From TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline (2022) · cites this paper as Yeung et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 1×
“Enhancing GluN2B-containing receptor activity can lead to excitotoxicity but increasing GluN2A receptors could be less excitotoxic with possibly more effective cognition restoring function (Bannerman et al., 2008; Hardingham & Bading, 2010).”
BackgroundFormation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 1×
“Aβ1–42 reduced GluN2B expression on glutamatergic neurons in mouse hippocampal cultures (Lacor et al., 2007).”
BackgroundBDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
Feldmeyer, D., Lübke, J., Silver, R. A., & Sakmann, B. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.012959 · Cited by 656
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
Presynaptic Regulation of Quantal Size by the Vesicular Glutamate Transporter VGLUT1
Wilson, N. R., Kang, J., Hueske, E. V., Leung, T., Varoqui, H., Murnick, J. G., Erickson, J. D., & Liu, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3003-04.2005 · Cited by 335 · cited 4×
“As a result, blocking of NMDARs and AMPARs result in increased expression of VGluTs (Wilson et al., 2005).”
BackgroundInfluentialDysfunction of NMDA receptors in Alzheimer’s disease
Zhang, Y., Li, P., Feng, J., & Wu, M. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2546-5 · Cited by 282
Lee, H.-K., Takamiya, K., He, K., Song, L., & Huganir, R. L. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00835.2009 · Cited by 261
Distribution of vesicular glutamate transporter mRNA in rat hypothalamus
Ziegler, D. R., Cullinan, W. E., & Herman, J. P. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10257 · Cited by 241
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
Chang, E. H., Savage, M. J., Flood, D. G., Thomas, J. M., Levy, R. B., Mahadomrongkul, V., Shirao, T., Aoki, C., & Huerta, P. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507313103 · Cited by 225 · cited 1×
“This is in agreement with findings of a double knockin amyloid precursor protein/PS-1 mouse AD study, which showed a reduction in membrane surface GluA1 expression in the str. radiatum of the CA1 region (Chang et al., 2006).”
ResultAltered synapses and gliotransmission in Alzheimer's disease and AD model mice
Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138
Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking
Guntupalli, S., Widagdo, J., & Anggono, V. (2016) · Neural Plasticity · doi:10.1155/2016/3204519 · Cited by 110
Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex
Henson, M. A., Roberts, A. C., Salimi, K., Vadlamudi, S., Hamer, R. M., Gilmore, J. H., Jarskog, L. F., & Philpot, B. D. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn017 · Cited by 110 · cited 1×
“GluN2B is more prominent in the early stages of fetal development, and decreases with age, while the quantity of GluN2A remain relatively constant, resulting in a progressive decrease in the GluN2B/GluN2A ratio in the receptors (Henson et al., 2008).”
BackgroundSchallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109 · cited 1×
“…Mallory, Alford, Tanaka, & Masliah, 1997; Ulas & Cotman, 1997; Yasuda et al., 1995) and mouse models (Cha et al., 2001; Minkeviciene et al., 2008; Schallier et al., 2011) have indicated significant changes in the expression of glutamate receptors and transporters in AD, which could have…”
BackgroundBoulland, J.-L., Jenstad, M., Boekel, A. J., Wouterlood, F. G., Edwards, R. H., Storm-Mathisen, J., & Chaudhry, F. A. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn077 · Cited by 107
Masurkar, A. V. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000412 · Cited by 68
Cercato, M. C., Vázquez, C. A., Kornisiuk, E., Aguirre, A. I., Colettis, N., Snitcofsky, M., Jerusalinsky, D. A., & Baez, M. V. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00242 · Cited by 55 · cited 12×
“Despite its central role in NMDAR function, there is only one study documenting changes in GluN1 subunit expression in AD (Sze, Bi, Kleinschmidt-DeMasters, Filley, & Martin, 2001), with most studies investigating the more adaptive GluN2A and GluN2B subunits.”
BackgroundInfluential
Research works printed but not linked: 78
- 10.1016/S0165-0173(98)00050-2 · DOI · Paper page
- 10.1007/BF02815205 · DOI
- 10.1016/0006-8993(94)91732-9 · DOI
- 10.1523/JNEUROSCI.3013-14.2015 · DOI
- 10.1093/cercor/bhp133 · DOI
- 10.1111/nmo.12233 · DOI
- 10.1523/JNEUROSCI.3639-07.2008 · DOI · Paper page
- 10.1016/S0022-510X(02)00087-4 · DOI
- 10.2165/00023210-200317090-00004 · DOI · Paper page
- 10.3390/molecules25030693 · DOI
- 10.1016/j.expneurol.2003.12.010 · DOI
- 10.1006/nbdi.2000.0330 · DOI
- 10.1016/S0959-4388(00)00215-4 · DOI · Paper page
- 10.1111/j.1476-5381.2012.02057.x · DOI · Paper page
- Dingledine R., 1999, The glutamate receptor ion channels, Pharmacological Reviews, 51, 7
- 10.1186/s13578-020-00393-4 · DOI
- 10.1016/j.ceca.2011.11.008 · DOI · Paper page
- 10.1111/j.1471-4159.1984.tb09689.x · DOI · Paper page
- 10.1126/science.1097468 · DOI · Paper page
- 10.1016/j.neuroscience.2017.03.041 · DOI
- 10.1016/j.mcn.2011.05.001 · DOI · Paper page
- 10.1016/0278-5846(88)90102-9 · DOI · Paper page
- 10.1002/hipo.10195 · DOI
- 10.1002/hipo.20006 · DOI
- 10.1046/j.1460-9568.2000.00164.x · DOI · Paper page
- 10.3389/fnana.2015.00130 · DOI
- 10.1523/JNEUROSCI.21-22-j0001.2001 · DOI · Paper page
- 10.1016/S0169-328X(00)00194-7 · DOI · Paper page
- 10.1126/science.1709304 · DOI · Paper page
- 10.1016/j.neuron.2006.10.035 · DOI · Paper page
- 10.1371/journal.pone.0140868 · DOI
- 10.1016/j.neuroscience.2016.09.027 · DOI
- 10.1110/ps.8.8.1668 · DOI · Paper page
- 10.1016/j.neurobiolaging.2007.04.010 · DOI · Paper page
- 10.1016/j.brainres.2005.06.081 · DOI
- 10.1523/ENEURO.0383-17.2018 · DOI
- 10.1111/j.1471-4159.2006.03935.x · DOI · Paper page
- 10.1016/j.neuroscience.2016.02.048 · DOI
- 10.1111/jnc.14325 · DOI
- 10.1038/srep21101 · DOI
- 10.1124/jpet.103.053694 · DOI
- 10.1523/JNEUROSCI.0849-05.2005 · DOI · Paper page
- 10.1210/en.2002-220908 · DOI
- 10.1016/0166-2236(87)90025-7 · DOI · Paper page
- 10.1016/j.neuron.2012.03.021 · DOI · Paper page
- 10.1016/j.neuroscience.2008.08.022 · DOI · Paper page
- 10.1212/WNL.34.7.939 · DOI · Paper page
- 10.1111/j.1471-4159.2007.05147.x · DOI · Paper page
- 10.1046/j.1460-9568.2003.02698.x · DOI · Paper page
- 10.1523/JNEUROSCI.2556-06.2006 · DOI · Paper page
- 10.1038/ncomms15800 · DOI
- 10.1016/j.hal.2018.08.008 · DOI
- 10.1101/lm.1398709 · DOI
- 10.1002/jnr.24214 · DOI
- 10.1016/j.expneurol.2007.10.008 · DOI · Paper page
- 10.1016/0028-3908(94)00129-G · DOI · Paper page
- 10.1002/hipo.22607 · DOI
- 10.1523/JNEUROSCI.0360-18.2018 · DOI
- 10.1016/j.nbd.2011.08.027 · DOI
- 10.3389/fncel.2019.00111 · DOI
- 10.1073/pnas.91.23.11158 · DOI
- 10.1016/0166-2236(96)10043-6 · DOI · Paper page
- 10.1016/S0022-510X(00)00467-6 · DOI
- 10.3390/nu9070686 · DOI
- 10.1073/pnas.0608807104 · DOI
- 10.1016/S0306-4522(97)00023-7 · DOI
- 10.1523/JNEUROSCI.22-01-00142.2002 · DOI · Paper page
- 10.1016/j.neuron.2017.09.024 · DOI · Paper page
- 10.1016/S0197-4580(99)00035-4 · DOI · Paper page
- 10.3389/fnmol.2011.00042 · DOI
- 10.1073/pnas.0401764101 · DOI · Paper page
- 10.3389/fncel.2018.00337 · DOI
- 10.1016/0006-8993(95)00178-S · DOI · Paper page
- 10.3389/fnins.2019.01427 · DOI
- 10.1016/j.expneurol.2008.01.011 · DOI
- Zhang B., 2018, Postsynaptic GluR2 involved in amelioration of Aβ‐induced memory dysfunction by Kaixin‐San through rescuing hippocampal LTP in mice, Rejuv Res
- 10.1155/2017/8197085 · DOI
- 10.1038/srep42788 · DOI
Cited by
Wang, C., Huang, W., Lu, J., Chen, H., & Yu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.763866 · Cited by 56
Metadata
- Authors
- Yeung, J. H. Y., Calvo‐Flores Guzmán, B., Palpagama, T. H., Ethiraj, J., Zhai, Y., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A.
- Affiliations
- Centre for Brain Research Department of Anatomy and Medical Imaging Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand
- Department of Biochemistry School of Biomedical Sciences University of Otago Dunedin New Zealand
- ORCID
- Kwakowsky, Andrea
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2020-07-02
- Volume
- 155
- Issue
- 1
- Pages
- 62-80
- ISSN
- 0022-3042
- 1471-4159
- Cited by
- 26
- References
- 20
- Language
- en
- Funders
- Freemasons New Zealand (3719321)
- Neurological Foundation of New Zealand (848010)
- Health Research Council of New Zealand (3627373)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.